CD38IgE

Pierre V Candelaria1, Miguel Nava1, Tracy R Daniels-Wells1

  • 1Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.

Cancers
|September 28, 2023
PubMed
概括

一种新的抗CD38 IgE抗体显示出治疗多发性骨髓瘤 (MM) 的前景. 这种工程抗体有效地向癌细胞并激活免疫反应,在临床前模型中延长存活时间.